21
Apr 2026
AI chatbots give misleading health advice nearly half the time
Widespread inaccuracies in AI chatbot health responses pose public health risks, highlighting the urgent need for better oversight and cleaner training data.
Stay Informed!
21
Apr 2026
Alzheimer’s monoclonal antibodies fail to deliver meaningful results
Despite reducing amyloid plaques, antibody treatments for Alzheimer's fail to improve cognition, highlighting critical gaps in current therapeutic approaches.
21
Apr 2026
Last patient has completed AlzeCure's Phase Ib clinical study with NeuroRestore ACD856
AlzeCure Pharma AB (publ), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the last patient’s last visit (LPLV) has now occurred in the ongoing Phase Ib clinical trial of ACD856, the lead drug candidate within the NeuroRestore platform, which is being developed for Alzheimer’s disease and other indications.
21
Apr 2026
Long-term exposure to air pollution (PM2.5) raises risk of developing cancer by 11 % and of dying from cancer by 12 %
The Union for International Cancer Control (UICC), with support from the Clean Air Fund, has released a global report, Clean air in cancer control: An overview of the evidence, presenting data on the scale of cancer risk and mortality from polluted air.
21
Apr 2026
New UWB technique helps pill-sized cameras overcome human body interference
Diagnostic tests for stomach conditions are tough for patients, as many of the most accurate ones involve minor surgical procedures or invasive techniques.
21
Apr 2026
DNA methylation "fingerprints" identify primary sites in metastatic cancers
A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22.
21
Apr 2026
Ibuprofen shown to improve cognitive function in patients undergoing chemotherapy
Researchers have already shown that mild to moderate exercise can reduce "chemo brain," and a new study suggests that a low dose of an over-the-counter anti-inflammatory, ibuprofen, can also achieve positive results for cancer patients.
21
Apr 2026
Early genomic testing prevents years of inconclusive visits for pediatric patients
For many families, eight years of uncertainty meant repeated specialist visits, inconclusive genetic tests and the growing fear that a clear answer might never come. For nearly half of the children enrolled in the Telethon Undiagnosed Disease Program (TUDP), that wait is now over.
21
Apr 2026
Clinical study confirms women's symptoms are de-prioritized in healthcare
Women have described being dismissed, disbelieved and left in serious pain during a routine womb examination that affects tens of thousands every year.
21
Apr 2026
Heatwaves above 38 °C significantly spike cardiovascular cases in middle-aged populations
A novel study has revealed a link between extreme weather and the risk of cardiovascular disease among middle-aged and older adults in 157 Chinese cities. Based on a city's climate and location, exposure to extreme heat, cold, and precipitation each increases the risk of heart disease. The findings of the study in the American Journal of Preventive Medicine, published by Elsevier, provide evidence for policymakers across different regions to develop targeted strategies protecting vulnerable populations during extreme climate events.
